Business Description
Poxel SA
ISIN : FR0012432516
Compare
Compare
Traded in other countries / regions
POXEL.France0RA2.UK7PO.GermanyPXXLF.USA IPO Date
2015-02-05Description
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.36 | |||||
| 9-Day RSI | 49.41 | |||||
| 14-Day RSI | 53.72 | |||||
| 6-1 Month Momentum % | 47.25 | |||||
| 12-1 Month Momentum % | -23.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -3239.76 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Poxel SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.674 | ||
| EPS (TTM) (€) | -1.08 | ||
| Beta | 1.4 | ||
| Volatility % | 72.31 | ||
| 14-Day RSI | 53.72 | ||
| 14-Day ATR (€) | 0.077257 | ||
| 20-Day SMA (€) | 0.64965 | ||
| 12-1 Month Momentum % | -23.8 | ||
| 52-Week Range (€) | 0.297 - 0.95 | ||
| Shares Outstanding (Mil) | 38.6 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Poxel SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Poxel SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Poxel SA Frequently Asked Questions
What is Poxel SA(XPAR:POXEL)'s stock price today?
The current price of XPAR:POXEL is €0.66. The 52 week high of XPAR:POXEL is €0.95 and 52 week low is €0.30.
When is next earnings date of Poxel SA(XPAR:POXEL)?
The next earnings date of Poxel SA(XPAR:POXEL) is 2024-05-16.
Does Poxel SA(XPAR:POXEL) pay dividends? If so, how much?
Poxel SA(XPAR:POXEL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers